Xiaolong Chen
Guiyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Elevated ICAM5 as a promising predictor of poor prognosis in bladder cancer via EMT, immune microenvironment, and therapy resistance.
Journal: PloS one
Published: October 16, 2025
CircCCDC66 promotes the progression and EMT of renal cell carcinoma via the miR-1278/HOXA13 axis.
Journal: Journal of translational medicine
Published: September 04, 2025
Renal pelvis urobiome dysbiosis is associated with postoperative systemic inflammatory response syndrome after percutaneous nephrolithotomy.
Journal: mSystems
Published: August 15, 2025
TRIP13-induced NUSAP1 upregulation promotes CcRCC progression through EMT and PI3K/AKT/mTOR pathway.
TRIP13-induced NUSAP1 upregulation promotes CcRCC progression through EMT and PI3K/AKT/mTOR pathway.
Journal: Journal of translational medicine
Published: January 23, 2025
Reprogramming of Glucose Metabolism by Nanocarriers to Improve Cancer Immunotherapy: Recent Advances and Applications.
Journal: International journal of nanomedicine
Published: December 19, 2024
Empagliflozin reduces renal calcium oxalate deposition in hyperoxaluria rats induced with ethylene glycol-ammonium chloride.
Journal: Biochemical and biophysical research communications
Published: July 30, 2024
Noncoding RNA, friend or foe for nephrolithiasis?
Journal: Frontiers in cell and developmental biology
Published: July 01, 2024
Nanoparticles targeting the adenosine pathway for cancer immunotherapy.
Journal: Journal of materials chemistry. B
Published: June 07, 2024
Inflammatory factors and the risk of urolithiasis: a bidirectional Mendelian randomization study.
Journal: Frontiers in medicine
Published: May 13, 2024
S100A9 promotes renal calcium oxalate stone formation via activating the TLR4-p38/MAPK-LCN2 signaling pathway.
Journal: International journal of biological macromolecules
Published: May 11, 2024
Last Updated: 09/26/2026